BIODANE PHARMA A/S: Financial statements 2013
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 106,251 and a net result of DKK -976,558 compared with DKK 8,087 the year before. That is a decrease of 72.4% compared with the year before. Equity amounted to DKK -263,048.
- Gross Profit
- 106,251 kr.
- Profit/Loss
- -976,558 kr.
- Equity
- -263,048 kr.
- Total Assets
- 607,289 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
Find more companies like BIODANE PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
BIODANE PHARMA A/S has published its annual report for 2012. Gross profit came to DKK 384,418, and the net result was DKK 8,087.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.
